HighTower Advisors, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2021$220,000
-12.0%
6,219
+0.5%
0.00%0.0%
Q1 2021$250,000
+5.5%
6,191
+11.8%
0.00%0.0%
Q4 2020$237,000
-34.3%
5,540
+22.5%
0.00%
-50.0%
Q4 2019$361,000
-51.9%
4,523
-77.8%
0.00%
-71.4%
Q1 2017$750,000
+152.5%
20,390
-0.5%
0.01%
+133.3%
Q4 2016$297,00020,4900.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders